WebApr 12, 2024 · BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body, announced today the appointment of industry veteran Patrick … WebMar 20, 2024 · Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United …

Cue Health Appoints Nitin Duggal as Chief Marketing Officer

WebApr 12, 2024 · BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of … WebMar 13, 2024 · Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com. Forward-Looking Statements Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking … slyman\\u0027s amherst ohio

Cue Health Reports Strong Fourth Quarter and Full Year 2024 …

WebSep 1, 2024 · SAN DIEGO, Sept. 1, 2024 /PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH) today announced that it has made a de novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue® Flu Molecular Test for at-home and point-of-care (POC) use. There are currently no flu tests on the market for home use. WebMar 7, 2024 · Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, and regulatory … WebApr 27, 2024 · SAN DIEGO -- (BUSINESS WIRE)--Apr. 27, 2024-- Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release … solar system gravity simulator